AVIVAGEN INCAVIVAGEN INCAVIVAGEN INC

AVIVAGEN INC

No trades
See on Supercharts
Market capitalization
‪388.47 K‬CAD
−0.060CAD
‪−6.07 M‬CAD
‪939.17 K‬CAD
‪76.97 M‬
Beta (1Y)
6.76

About AVIVAGEN INC

CEO
G. F. Kym Anthony
Headquarters
Ottawa
Founded
2005
ISIN
CA05382F2026
FIGI
BBG000KWRFT2
Avivagen, Inc. engages in the development and commercialization of products for livestock. Its products include OxC-beta Livestock, Vivamune Vital Health Chews and Oximunol Chewable Tablets. The company was founded by Janusz Daroszewsk and Graham W. Burton on August 4, 2005 and is headquartered in Ottawa, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VIV is 0.005 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange AVIVAGEN INC stocks are traded under the ticker VIV.
AVIVAGEN INC is going to release the next earnings report on Jun 4, 2024. Keep track of upcoming events with our Earnings Calendar.
VIV stock is 0% volatile and has beta coefficient of 6.76. Check out the list of the most volatile stocks — is AVIVAGEN INC there?
VIV earnings for the last quarter are −0.03 CAD per share, whereas the estimation was −0.03 CAD resulting in a −20.00% surprise. The estimated earnings for the next quarter are −0.02 CAD per share. See more details about AVIVAGEN INC earnings.
AVIVAGEN INC revenue for the last quarter amounts to ‪48.61 K‬ CAD despite the estimated figure of ‪200.00 K‬ CAD. In the next quarter revenue is expected to reach ‪175.00 K‬ CAD.
Yes, you can track AVIVAGEN INC financials in yearly and quarterly reports right on TradingView.
VIV net income for the last quarter is ‪−932.92 K‬ CAD, while the quarter before that showed ‪−1.24 M‬ CAD of net income which accounts for 25.06% change. Track more AVIVAGEN INC financial stats to get the full picture.
No, VIV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VIV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AVIVAGEN INC stock right from TradingView charts — choose your broker and connect to your account.
VIV reached its all-time high on Feb 19, 2007 with the price of 4.100 CAD, and its all-time low was 0.005 CAD and was reached on Sep 6, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AVIVAGEN INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AVIVAGEN INC stock shows the sell signal. See more of AVIVAGEN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AVIVAGEN INC EBITDA is ‪−2.89 M‬ CAD, and current EBITDA margin is −517.55%. See more stats in AVIVAGEN INC financial statements.